Cargando…
Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity
The poor prognosis of most cases of advanced cholangiocarcinoma (CCA) constitutes a severe problem in modern oncology, which is aggravated by the fact that the incidence of this liver cancer is increasing worldwide and is often diagnosed late, when surgical removal is not feasible. The difficulty of...
Autores principales: | Lozano, Elisa, Sanchon-Sanchez, Paula, Morente-Carrasco, Ana, Chinchilla-Tábora, Luis Miguel, Mauriz, José L., Fernández-Palanca, Paula, Marin, Jose J. G., Macias, Rocio I. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136857/ https://www.ncbi.nlm.nih.gov/pubmed/37190050 http://dx.doi.org/10.3390/cells12081141 |
Ejemplares similares
-
Novel Pharmacological Options in the Treatment of Cholangiocarcinoma: Mechanisms of Resistance
por: Marin, Jose J. G., et al.
Publicado: (2021) -
Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma
por: Alonso-Peña, Marta, et al.
Publicado: (2019) -
Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis
por: Fondevila, Flavia, et al.
Publicado: (2021) -
Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma
por: Marin, Jose J.G., et al.
Publicado: (2020) -
Beneficial effects of melatonin on liver fibrosis: A systematic review of current biological evidence
por: San‐Miguel, Beatriz, et al.
Publicado: (2022)